154 related articles for article (PubMed ID: 24936706)
21. Dolichol is the major lipid component of human substantia nigra neuromelanin.
Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B
J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500
[TBL] [Abstract][Full Text] [Related]
22. Unraveling the contributions to the neuromelanin-MRI contrast.
Priovoulos N; van Boxel SCJ; Jacobs HIL; Poser BA; Uludag K; Verhey FRJ; Ivanov D
Brain Struct Funct; 2020 Dec; 225(9):2757-2774. PubMed ID: 33090274
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.
Langley J; Huddleston DE; Liu CJ; Hu X
MAGMA; 2017 Apr; 30(2):121-125. PubMed ID: 27687624
[TBL] [Abstract][Full Text] [Related]
24. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra.
Bing G; Zhang Y; Watanabe Y; McEwen BS; Stone EA
Brain Res; 1994 Dec; 668(1-2):261-5. PubMed ID: 7704612
[TBL] [Abstract][Full Text] [Related]
25. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
26. Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain.
Ward WC; Guan Z; Zucca FA; Fariello RG; Kordestani R; Zecca L; Raetz CR; Simon JD
J Lipid Res; 2007 Jul; 48(7):1457-62. PubMed ID: 17446624
[TBL] [Abstract][Full Text] [Related]
27. Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus.
Iannitelli AF; Segal A; Pare JF; Mulvey B; Liles LC; Sloan SA; McCann KE; Dougherty JD; Smith Y; Weinshenker D
bioRxiv; 2023 Mar; ():. PubMed ID: 36945637
[TBL] [Abstract][Full Text] [Related]
28. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
29. Chemical degradation of melanins: application to identification of dopamine-melanin.
Ito S; Wakamatsu K
Pigment Cell Res; 1998 Apr; 11(2):120-6. PubMed ID: 9585251
[TBL] [Abstract][Full Text] [Related]
30. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
32. Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast.
Nakane T; Nihashi T; Kawai H; Naganawa S
Magn Reson Med Sci; 2008; 7(4):205-10. PubMed ID: 19110515
[TBL] [Abstract][Full Text] [Related]
33. Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration.
Szot P; Franklin A; Sikkema C; Wilkinson CW; Raskind MA
Front Pharmacol; 2012; 3():184. PubMed ID: 23129999
[TBL] [Abstract][Full Text] [Related]
34. Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis.
Tribl F; Arzberger T; Riederer P; Gerlach M
J Neural Transm Suppl; 2007; (72):51-5. PubMed ID: 17982878
[TBL] [Abstract][Full Text] [Related]
35. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
36. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS
Brain Res; 2003 Nov; 989(2):205-13. PubMed ID: 14556942
[TBL] [Abstract][Full Text] [Related]
37. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.
Sulzer D; Cassidy C; Horga G; Kang UJ; Fahn S; Casella L; Pezzoli G; Langley J; Hu XP; Zucca FA; Isaias IU; Zecca L
NPJ Parkinsons Dis; 2018; 4():11. PubMed ID: 29644335
[TBL] [Abstract][Full Text] [Related]
38. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
[TBL] [Abstract][Full Text] [Related]
39. Neuromelanin of the human substantia nigra: a mixed-type melanin.
Odh G; Carstam R; Paulson J; Wittbjer A; Rosengren E; Rorsman H
J Neurochem; 1994 May; 62(5):2030-6. PubMed ID: 8158151
[TBL] [Abstract][Full Text] [Related]
40. Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T.
Lee H; Baek SY; Chun SY; Lee JH; Cho H
Neuroimage; 2018 May; 172():874-885. PubMed ID: 29162523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
